Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPci-pal Regulatory News (PCIP)

Share Price Information for Pci-pal (PCIP)

Share Price is delayed by 15 minutes
Get Live Data
45.50    -1.30 (-2.78%)
Bid:
45.00
Ask:
46.00
Spread: 1.00 (2.222%)
Market Cap: £32.97m
PCIP Live PriceLast checked at - London Stock Exchange

Intraday Pci-pal Share Chart

Completion of Disposal & Company Changes Update

30 Sep 2016 13:00

RNS Number : 3669L
IPPlus PLC
30 September 2016
 

 

IPPLUS PLC

("IPPLUS" or the "Group")

 

Completion of Disposal,

Change of Name and Registered Office,and Board Changes

 

IPPlus PLC (AIM: IPP), the customer engagement specialist focussed on telephony and secure payment solutions, is pleased to announce that following the successful passing of all resolutions put to the general meeting held on 30 September 2016 (the "General Meeting"), the disposal of IPPlus (UK) Limited and CallScripter Limited (the "Disposal") has now completed and as a result IPPlus has exited its call centre operations.

 

New Focus and Available Resources

 

Following completion and including the proceeds of a property sale, the continuing Group now has approximately £4.8 million in net cash. A further announcement will be made in relation to the proposed special dividend of £1 million to shareholders. The Group will now focus its efforts and resources on the significant opportunities in secure payments presented by its PCI-PAL products and services, in which both the client base and transaction volumes have been growing.

 

Change of Name and Registered Office, New Trading Symbol ("PCIP")

 

Following shareholder approval to the change of name at the General Meeting, the Group is pleased to announce that its new name of PCI-PAL PLC has been registered at Companies House today, and is now effective. The new name reflects the sole focus of the Group on its secure payments solutions business. The Company also confirms that it has changed its registered office with immediate effect to Unit 7, Gamma Terrace, Masterlord Estate, Ipswich IP3 9FF.

 

It is expected that trading in the Company's shares on AIM under the new name of PCI-PAL PLC and under the TIDM1 "PCIP" will commence with effect from 8.00am on Monday 3 October 2016. Certificated shares held in the old name of IPPlus PLC remain valid.

 

Board Changes

 

To support the planned growth in its business, PCI-PAL PLC is pleased to announce the appointment of James Barham and Andy Francombe to its Board of Directors. Andy Francombe joins as Chief Financial Officer and James Barham is promoted to Commercial Director.

 

James Christopher Barham, aged 34, graduated from Bath Spa University and worked for Hiscox Plc and Call Connection Ltd before joining IPPlus in 2008, where he held several senior management positions before being appointed to the Board of IPPlus (UK) Limited in 2015. James has been instrumental in the growth of the telecoms and payments businesses and the ultimate evolution of the PCI-PAL product suite. James is responsible for sales, operations and commercial development.

 

Andrew ('Andy') Kevin Francombe, aged 53, is a Fellow of the Institute of Chartered Accountants in England & Wales having qualified with Ernst & Young. Andy has held senior finance roles for The Coca-Cola Company in Europe and Macquarie Bank, in addition to being Finance Director at Conran Restaurants and Deputy Finance Director at Schweppes Beverages.

 

Finally, as outlined in the Company circular published in connection with the disposal, Stuart Gordon has resigned from the Board with immediate effect. The Board would like to thank Stuart for his many years of service and wishes him well in his future endeavours.

 

William Catchpole, Chief Executive Officer of PCI-PAL PLC, commented:

 

"This marks the beginning of our next phase of growth and is a very exciting time for the business. The opportunities to grow our secure payments operations are without doubt considerable. We have an excellent team in place and cash resources to pursue our strategy."

 

Additional information required under the AIM Rules in relation to the newly appointed Directors is included below.

 

(1) Tradable Instrument Display Mnemonic, the code used to identify a traded quoted security

 

 

For further details, please contact:

 

 

PCI-PAL PLC 

William Catchpole - Chief Executive Officer

Andy Francombe - Chief Financial Officer

 

 

Via Walbrook PR

N+1 Singer (Nomad & Broker) 

Aubrey Powell

 

+44 (0) 20 7496 3000

Walbrook PR

 

Tom Cooper / Paul Vann

 

+44 (0) 20 7933 8780

+44 (0) 7971 221 972

tom.cooper@walbrookpr.com

 

 

 

 

About PCI-PAL PLC:

 

The Group currently has a single principal business, PCI-PAL, which provides products and services that enable organisations to securely take customer payments, safely store customer data, in particular credit card data, and to de-risk their business activities from the threat of data loss and cybercrime. The Group's shares are admitted to trading on AIM under the symbol, "PCIP".

 

 

 

Regulatory Information

The following additional details in relation to the appointments of James Barham and Andy Francombe are disclosed in accordance with Schedule 2(g) of the AIM Rules:

 

Name/ Company

Date of Appointment

Date of Resignation

 

James Barham

 

Current Directorships:

 

 

PCI-PAL Limited

October 2011

-

IP3 Telecom Limited

January 2011

-

Directorships held within last 5 years:

IPPlus (UK) Limited

January 2015

September 2016

 

Andy Francombe (Current Directorships)

 

Coca-Cola UK Pension Trustees Limited

 

2010

-

PrimeFd LLP

August 2016

-

Aten Group Limited

September 2016

-

 

There is no further information required to be disclosed in accordance with Schedule 2(g) or Rule 17 of the AIM Rules.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCDMGFLMGNGVZM
Date   Source Headline
14th Apr 20267:00 amRNS-RHIPAA, HITRUST & SOC 2 Type II certification
18th Mar 20267:00 amRNS-RMajor New Reseller Partnership with Global Telco
10th Mar 20263:07 pmRNSHolding(s) in Company
10th Mar 20263:07 pmRNSHolding(s) in Company
3rd Mar 20267:00 amRNSInterim Results, Analyst Briefing & Investor Pres
23rd Feb 20267:00 amRNS-RNew Major Strategic Reseller Partnership
17th Feb 20267:00 amRNSNotice of Results, Analyst Briefing, Investor Pres
10th Feb 20265:07 pmRNSHolding(s) in Company
6th Feb 202611:26 amRNSHolding(s) in Company
6th Feb 202611:25 amRNSHolding(s) in Company
5th Feb 202612:48 pmRNSHolding(s) in Company
3rd Feb 20267:00 amRNSTrading Update
18th Dec 20254:44 pmRNSGrant of Options under Long-Term Incentive Plan
18th Dec 20254:44 pmRNSGrant of Options under Long-Term Incentive Plan
1st Dec 20252:49 pmRNSResult of AGM
19th Nov 20257:00 amRNS-RStrategic US Healthcare Sector Integration
17th Nov 20253:19 pmRNS-RCMD Presentation Video
14th Nov 20257:00 amRNS-RCMD Presentation & MelloLondon
11th Nov 20257:00 amRNSCapital Markets Day
6th Nov 20254:20 pmRNSAnnual Financial Report & Notice of AGM
25th Sep 20258:45 amRNSHolding(s) in Company
9th Sep 20257:00 amRNSFinal Results, Analyst Briefing & Investor Pres
19th Aug 20257:00 amRNSNotice of Results, Analyst Briefing, Investor Pres
30th Jul 20253:18 pmRNSDirector Share Purchases
29th Jul 202510:20 amRNSDirector Share Purchase
29th Jul 20257:01 amRNSTrading & Business Update
29th Jul 20257:00 amRNSNew Product Launch
1st Jul 20257:00 amRNSBoard Changes
20th Jun 202512:00 pmRNSIssue of Equity & TVR
3rd Apr 20259:24 amRNSHolding(s) in Company
12th Mar 20253:20 pmRNSDirector Share Purchases
10th Mar 20257:00 amRNS-RPCI Pal and RingCentral Inc Partnership
6th Mar 20252:00 pmRNSPDMR Issue of Options
4th Mar 20253:49 pmRNSDirector Share Purchase
4th Mar 20257:00 amRNSInterim Results, Analyst Briefing & Investor Pres
18th Feb 20257:00 amRNSNotice of Results, Analyst Briefing, Investor Pres
27th Jan 20257:00 amRNSTrading Update
11th Dec 20242:42 pmRNSHolding(s) in Company
11th Dec 20242:17 pmRNSResult of AGM
11th Dec 20247:00 amRNSAGM Statement
6th Dec 20244:10 pmRNSExercise of Options & TVR
14th Nov 20244:23 pmRNSAnnual Financial Report & Notice of AGM
22nd Oct 20247:00 amRNSFinal Results, Analyst Briefing & Investor Pres
14th Oct 20247:00 amRNSConfirmation of CFO Appointment
19th Sep 20247:00 amRNSAudit Update & Timing of Results
10th Sep 20244:46 pmRNSHolding(s) in Company
28th Aug 20247:00 amRNSTrading Update, New Partner & Notice of Results
22nd Jul 20249:15 amRNSHolding(s) in Company
1st Jul 20245:23 pmRNSExercise of Options, Director Shareholding & TVR
1st Jul 20247:00 amRNSBoard Changes - Appointment of CFO

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.